Prospective Studies of C-Reactive Protein as a Risk Factor for Cardiovascular Disease

Journal of Investigative Medicine

Volumn 46, Issue 8, 1998, Pages 391-395

  Ridker, Paul M ^a   Haughie, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTERIOSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REVIEW; RISK FACTOR;

ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC STUDIES; HUMANS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032185703     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ross T. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
3. Ridker PM, Cushman M, Stampfer MJ, Tracey RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336-973-9.
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
5. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11.
6. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
7. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-47.
8. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
9. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactivge protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
10. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
11. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-66.
12. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E for the Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998;98:839-44.
13. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference interval and epidemiological applications. Clin Chem 1997;43:52-8.
14. Wilkins J, Gallimore R, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998;44:1358-61.
15. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary disease. Am J Cardiol 199;65:168-72.
16. Koenig W, Froehlich M, Sund M, Doering A, Fischer HG, Lowel H, Hutchinson W, Pepyes MB. C-Reactive protein predicts risk of coronary heart disease in middle-aged men: results from the MONICA Augsberg Cohort Study, [abstract]. Circulation 1997;96:199.
17. Tracy RP. Inflammation in cardiovascular disease. Cart, horse, or both? Circulation 1998;97:2000-2.
18. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
19. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20.
20. Reynolds GD, Vance RP. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987;111:265-9.
21. Buchta R, Pontet M, Fiedkin M. Binding of C-reactive protein to human neutrophils. FEBS Lett 1987;211:165-8.
22. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJM, Hack CE. C-reactive protein mediated activation of complement in vivo. Assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 1996;157:473-9.
23. Zouki C, Beauchamp M, Baron C, Filep JG. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest 1997;100:522-9.
24. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
25. Bataille R, Kelin B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992;35:982-4.
26. Ridker PM. Inflammation, infection, and cardiovascular disease: how good is the clinical evidence? Circulation 1998;98:1671-4.